Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Association of hepatitis C virus envelope proteins with exosomes.

Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TS, Houghton M, Pileri P, Abrignani S.

Eur J Immunol. 2004 Oct;34(10):2834-42.

2.

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

Mazzocca A, Sciammetta SC, Carloni V, Cosmi L, Annunziato F, Harada T, Abrignani S, Pinzani M.

J Biol Chem. 2005 Mar 25;280(12):11329-39. Epub 2004 Dec 16.

3.

Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

Allander T, Forns X, Emerson SU, Purcell RH, Bukh J.

Virology. 2000 Nov 25;277(2):358-67.

4.

Host cell responses induced by hepatitis C virus binding.

Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J, Geyer M, Walz G, Depla E, von Weizsäcker F, Blum HE, Baumert TF.

Hepatology. 2006 Jun;43(6):1326-36.

5.

Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

Drummer HE, Wilson KA, Poumbourios P.

Biochem Biophys Res Commun. 2005 Mar 4;328(1):251-7.

PMID:
15670777
6.

Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.

Shaw ML, McLauchlan J, Mills PR, Patel AH, McCruden EA.

J Med Virol. 2003 Jul;70(3):361-72.

PMID:
12766998
7.

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.

Rocha-Perugini V, Lavie M, Delgrange D, Canton J, Pillez A, Potel J, Lecoeur C, Rubinstein E, Dubuisson J, Wychowski C, Cocquerel L.

BMC Microbiol. 2009 May 28;9:111. doi: 10.1186/1471-2180-9-111.

8.

Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.

Codran A, Royer C, Jaeck D, Bastien-Valle M, Baumert TF, Kieny MP, Pereira CA, Martin JP.

J Gen Virol. 2006 Sep;87(Pt 9):2583-93.

PMID:
16894197
9.

The GBV-C envelope glycoprotein E2 does not interact specifically with CD81.

Kaufman TM, McLinden JH, Xiang J, Engel AM, Stapleton JT.

AIDS. 2007 May 11;21(8):1045-8.

PMID:
17457101
10.

A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.

Tao W, Xu C, Ding Q, Li R, Xiang Y, Chung J, Zhong J.

Virology. 2009 Dec 5;395(1):67-76. doi: 10.1016/j.virol.2009.09.006. Epub 2009 Sep 30.

11.

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.

Nattermann J, Zimmermann H, Iwan A, von Lilienfeld-Toal M, Leifeld L, Nischalke HD, Langhans B, Sauerbruch T, Spengler U.

Hepatology. 2006 Oct;44(4):945-54.

PMID:
17006905
12.

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18544-9. Epub 2005 Dec 9.

13.

Hepatitis C virus (HCV): a review of immunological aspects.

Irshad M, Khushboo I, Singh S, Singh S.

Int Rev Immunol. 2008;27(6):497-517. doi: 10.1080/08830180802432178. Review.

PMID:
19065353
14.

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.

Perrault M, Pécheur EI.

Biochem J. 2009 Oct 12;423(3):303-14. doi: 10.1042/BJ20091000. Review.

PMID:
19807698
15.

Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.

Wagner CE, Mohler ML, Kang GS, Miller DD, Geisert EE, Chang YA, Fleischer EB, Shea KJ.

J Med Chem. 2003 Jul 3;46(14):2823-33.

PMID:
12825926
16.

In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.

Wunschmann S, Muller HM, Stipp CS, Hemler ME, Stapleton JT.

J Infect Dis. 2006 Oct 15;194(8):1058-67. Epub 2006 Sep 8.

PMID:
16991080
17.

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.

J Viral Hepat. 2004 Nov;11(6):519-26.

PMID:
15500552
18.

Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus.

Migliaccio CT, Follis KE, Matsuura Y, Nunberg JH.

Virus Res. 2004 Sep 15;105(1):47-57.

PMID:
15325080
19.

CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.

Lyra AC, Fan X, Di Bisceglie AM.

Braz J Infect Dis. 2004 Apr;8(2):126-32. Epub 2004 Sep 8.

PMID:
15361990
20.

Supplemental Content

Support Center